Melatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: A randomized double-blind placebo-controlled trial

Acta Medica Iranica

Volumn 52, Issue 10, 2014, Pages 734-739

  Mostafavi, Ali ^a   Solhi, Mahmoud ^a   Mohammadi, Mohammad Reza ^a   Hamedi, Mehdi ^a   Keshavarzi, Maryam ^a   Akhondzadeh, Shahin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bipolar disorder; Melatonin; Metabolic Syndrome; Olanzapine

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LIPID; LITHIUM CARBONATE; MELATONIN; NEUROLEPTIC AGENT; OLANZAPINE;

ADOLESCENT; BIPOLAR DISORDER; BLOOD; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPIDS; LITHIUM CARBONATE; MALE; MELATONIN; SEX FACTORS;

EID: 84928889136     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Correll CU, Carlson HE. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 2006;45(7):771-91.
2. Calarge CA, Acion L, Kuperman S, et al. Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents. J Child Adolesc Psychopharmacol 2009;19(2):101-9.
3. Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005;111(15):1999-2012.
4. Newcomer JW, Haupt DW. The metabolic effects of antipsychotic medications. Can J Psychiatry 2006; 51(8):480-91.
5. Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 2004;70(1):1-17.
6. Laita P, Cifuentes A, Doll A, et al. Antipsychotic-related abnormal involuntary movements and metabolic and endocrine side effects in children and adolescents. J Child Adolesc Psychopharmacol 2007;17(4):487-502.
7. Cagnacci A. Melatonin in relation to physiology in adult humans. J Pineal Res 1996;21(4):200-13.
8. Mohammadi MR, Mostafavi SA, Keshavarz SA, et al. Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iranian J Psychiatry 2012;7(2):87-92.
9. Cardinali DP, Cano P, Jimenez-Ortega V, et al. Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications. Neuroendocrinology 2011;93(3):133-42.
10. Mostafavi SA, Mohammadi MR, Hosseinzadeh P, et al. Dietary intake, growth and development of children with ADHD in a randomized clinical trial of Ritalin and Melatonin co-administration: Through circadian cycle modification or appetite enhancement? Iranian J psychiatry 2012;7(3):114-9.
11. Cardinali DP, Pagano ES, Scacchi Bernasconi PA, et al. Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin. Neuro Endocrinol Lett 2011;32(5):588-606.
12. Tan DX, Manchester LC, Fuentes-Broto L, et al. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 2011;12(3):167-88.
13. Akhondzadeh S, Milajerdi MR, Amini H, et al. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Bipolar Disord 2006;8(5 Pt 1):485-9.
14. Amrollahi Z, Rezaei F, Salehi B, et al. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 2011;129(1-3):327-31.
15. Saroukhani S, Emami-Parsa M, Modabbernia A, et al. Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebocontrolled study. Bipolar Disord 2013;15(6):650-6.
16. Modabbernia A, Heidari P, Soleimani R, et al. Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study. J Psychiatric Res 2014;53:133-40.
17. Raskind MA, Burke BL, Crites NJ, et al. Olanzapineinduced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats. Neuropsychopharmacology 2007;32(2):284-8.
18. Kozirog M, Poliwczak AR, Duchnowicz P, et al. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 2011;50(3):261-6.